Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016-Reference-Cited by-同舟云学术

Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016

Published:2020-06-24 Issue:6 Volume:3 Page:e207664
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Soprano Samantha E.¹²,Hennessy Sean¹²³⁴,Bilker Warren B.¹²⁵,Leonard Charles E.¹²³

Affiliation:

1. Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia

2. Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia

3. Center for Therapeutic Effectiveness Research, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia

4. Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia

5. Neuropsychiatry Section, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2767591/soprano_2020_oi_200329.pdf

Reference18 articles.

1. Skeletal muscle relaxants.;See;Pharmacotherapy,2008

2. Re: Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain: a systematic review within the framework of the Cochrane collaboration. Spine 2003;28:1978-92.;Manniche;Spine (Phila Pa 1976),2004

3. Carisoprodol: abuse potential and withdrawal syndrome.;Reeves;Curr Drug Abuse Rev,2010